logo

FDA Calendar

Share SHARE
Company Name Otonomy Inc.
Drug Name OTIPRIO(sNDA)
Event Name FDA decision on OTIPRIO for acute otitis externa
Event Date 03/02/2018
Outcome Date
Outcome
Drug Status
Rival Drugs
Market Potential
Other Approvals OTIPRIO is already approved for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement.
News
Return to FDA Calendar